Start: Jan 26, 2018
End: Jan 27, 2018

NOTE: The statements made in the presentations below are the authors', and do not necessarily reflect the views of, and are not endorsed by, Accuray Incorporated or its affiliates. Such statements should not be construed as medical advice.

New thinking on fractionation in radiotherapy
Alan Nahum | The University of Liverpool, United Kingdom
Introduction and program overview
Maria do Carmo Lopes | Portuguese Institute of Oncology, Coimbra, Portugal
TomoTherapy/Radixact Breast
Breast cancer: Clinical evidence of new treatments
Roberto Orecchia | European Institute of Oncology (IEO), Milan, Italy
Strengthening the weakest link: Improving tumour definition
Marianne Aznar | The University of Manchester, Manchester, United Kingdom
CyberKnife Spine
Dose planning strategies to envision retreatments
Andrei Fodor | Hospital San Raffaele, Milan, Italy
CyberKnife Pancreas
Pancreas cancer: Characterization of bowel movements and impact on SBRT treatments
Mauro Loi | Erasmus MC, Rotterdam, The Netherlands
Novel techniques for normal tissue toxicity modeling
Laura Cella | National Research Council of Italy (CNR), Naples, Italy
Key note: Innovation and safety: patients first
Florian Sterzing | Strahlentherapie Süd, Kaufbeuren, Germany
Head and Neck
Adaptive approach in head and neck cancers
Coen Rasch | Academic Medical Center (AMC), Amsterdam, The Netherlands
CyberKnife Prostate
Hypofractionation for prostate cancer: Is it the new standard of care?
Nicholas van As | The Royal Marsden, NHS Foundation Trust, London, United Kingdom
CyberKnife Oligometastases
SBRT for oligometastases: Picking the finest cherries
Piet Ost | Ghent University Hospital, Ghent, Belgium
VLADI: An alternative to anesthesia in radiotherapy treatments
Ana Roma Calçarão | Cliniques Universitaires Saint-Luc, Brussels, Belgium
Combination of immunotherapy and precision therapy
Eric Deutsch | Gustave Roussy, Paris, France
Conclusion of the Meeting
Barbara A. Jereczek-Fossa | IEO Instituto Europeo di Oncologia, Milan, Italy
CyberKnife Prostate
Curative approach for prostate cancer with 1-2 bone metastases?
Mack Roach III | University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA
CyberKnife Spine
Vertebral body compression fractures following spine SBRT
Kristin J. Redmond | Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA
Management of brain metastases WBRT vs. SRS
Rami El Shafie | Heidelberg University Hospital, Heidelberg, Germany
“One stop shop"
Natalie D. Klass | Erasmus MC, Rotterdam, The Netherlands
The rationale for more than palliation in palliation
Vincent Khoo | The Royal Marsden, NHS Foundation Trust, London, United Kingdom